Drug Trial Radar · NCT04312997
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
Last checked: Nov 19, 2026Latest source record: Apr 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
101
Actual
Start
Jun 16, 2020
Primary completion
Jul 2, 2021
Study completion Jul 2, 2021
Sponsor
- Lead sponsor
- Pulmotect, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- United States Department of Defense
- First posted
- Mar 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Adults who have tested positive for SARS-CoV-2 infection and who may require supplemental oxygen will receive PUL-042 Inhalation Solution or placebo 3 times over a one week period in addition to their normal care. Subjects will be be followed and assessed for their clinical status over 28 days to see if PUL-042 Inhalation Solution improves the clinical outcome
Conditions
- COVID-19
Interventions
PUL-042 Inhalation SolutionDrug
20.3 µg Pam2 : 29.8 µg ODN/mL (50 µg PUL-042)
PlaceboDrug
Sterile saline for inhalation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Worsening of COVID-19 Within 28 DaysTime frame: 28 days
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
University of California Irvine
Orange, California
Premeir Urgent Care of California
San Bernardino, California
Clinical Research of South Florida Alliance for Multispecialty Research
Coral Gables, Florida
Invesclinic US LLC
Fort Lauderdale, Florida
DBC Research Corp.
Tamarac, Florida
Affinity Clinical Research, LLC
Tampa, Florida
St. Elizabeth Healthcare
Edgewood, Kentucky
Ascension St. John
Bartlesville, Oklahoma
Ascension St. John
Tulsa, Oklahoma
MD Anderson Cancer Center
Houston, Texas
Next Level Urgent Care
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.